Hide Board Information

Show Board Information

Pinnacle Airlines Corp. PNCLQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/11/2014 12:52:11 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Pinnacle Airlines Corp. (OTCMRKTS: PNCLQ) Stock Message Board

1. PNCLQ Company Profile

    

2. PNCLQ Time & Sales

    

3. PNCLQ Recent News

    

4. PNCLQ Filings

    

5. PNCLQ Financials

    

6. PNCLQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	Latest Pinnacle Airlines (PNCLQ) Headlines FREE	Stock_Tracker	03/11/2014 12:52:11 AM
7	PNCLQ Omnibus Hearing Scheduled for December 12,	WARMBUFFETT	12/10/2012 1:19:54 PM
6	This is ready to move forward, get in on the	Depcom	11/25/2012 12:24:20 AM
5	Dispatchers at Pinnacle Airlines ratify	Depcom	11/25/2012 12:23:10 AM
4	Pinnacle Airlines flight attendants ratify deal	Depcom	11/25/2012 12:21:51 AM
3	Court Issues Section 1113 Decision Regarding	Depcom	11/25/2012 12:21:11 AM
2	US bankruptcy court rules on Pinnacle Airlines,	Depcom	11/25/2012 12:20:38 AM
1	Pinnacle Airlines close to deal with pilots,	Depcom	11/25/2012 12:18:49 AM

Recent Articles

• Projected Chillers Market Growth and Key Industry Trends
• Exploring the Concept of Corporate Bootlickers in Today's Workforce
• Chillers Market Expected to Reach $15.42 Billion by 2029
• Fangzhou Inc. Joins Hang Seng Composite Index – A Milestone
• Growing Cybersecurity Challenges for Global Manufacturers
• Arrowpoint Partners Engages SS&C for Hedge Fund Management
• Discover Huangshan: A Premier Destination for Global Travelers
• Bill Lowen Triumphs Again at Bassmaster Elite Championship
• Arrowpoint Investment Partners Selects SS&C for Fund Services
• Rising Cybersecurity Threats Facing Manufacturers Globally
• LG Display Unveils Massive Automotive Displays for Future Cars
• The Future of Frozen Desserts: Innovations and Health Trends Ahead
• Innovent's Ipilimumab Injection Receives Priority Review for Colon Cancer
• Future of Dental Restorative Materials: An $887 Million Market
• Dr. Gregory George Strengthens Mesoblast's Board Team
• Dr. Gregory George Appointed to Mesoblast Board of Directors
• The Shift Toward a Multipolar World: Challenges and Opportunities
• Neumora Therapeutics Faces Class Action Amid Share Price Decline
• THON Achieves $17.7 Million in Record-Setting Fundraiser
• Samson Mow Advocates Ethereum Blockchain Reversal After Theft
• Impressive Half-Year Financial Surge for Perseus Mining
• Micron Technology Investors: Join Class Action Lawsuit Today
• Investors in BioAge Labs, Inc. Can Lead Class Action Against Firm
• Class Action Lawsuit Filed Against Crocs, Inc. Investors Alert
• Shifting Global Dynamics: A Call for New Leadership in Trade
• Saipem and Subsea7: A New Era in Energy Services Merger
• Disney's Leadership Insight: The Critical Necessity of Decency
• Investors of ICON PLC Face Class Action Lawsuit Opportunities
• Join the Class Action Against Constellation Brands for Losses
• Lessons on Financial Prudence from Charlie Munger
• Warren Buffett's Annual Insights: A Guide to Investing Wisely
• Investors of TransMedics Group Urged to Act Before Class Deadline
• Mark Cuban's Take on Political Messaging and Sales Skills
• MrBeast Reflects on Huge Losses from 'Beast Games' Production
• The Trade Desk, Inc. Class Action Lawsuit Update and Guidance
• Robinhood's Vision: How Prediction Markets Will Transform Trading
• Choosing Between Homeownership and Restaurant Investment
• Apple Shifts Strategy with the iPhone 16e Launch Announcement
• Unlocking the Secrets of Chris Camillo's Investment Success
• Understanding the Class Action Against Regeneron Pharmaceuticals
• Friedrich Merz Set to Lead Germany After Election Results
• Massive $1.4 Billion Ethereum Heist Shakes Crypto World
• Investors Target FTAI Aviation Ltd. in Class Action Lawsuit
• IO Biotech Expands Cancer Vaccine Research with New Findings
• Exciting Advances in Cancer Vaccine Development by IO Biotech
• Berkshire Hathaway's Cash Reserves: Buffett's Invaluable Insights
• Top Mid-Cap Stocks Surge: Insights on Impressive Gains
• Analyzing Recent Declines: Are Your Stocks in Trouble?
• ESSA Pharma Inc. Investors Prepare for Key Class Action Deadline
• Insights from Michael Wolff's Book on Trump: Secrets Revealed